Standout Papers

IFN-γ–related mRNA profile predicts clin... 2005 2026 2012 2019 2.3k
  1. IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade (2017)
    Mark Ayers, Jared Lunceford et al. Journal of Clinical Investigation
  2. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy (2005)
    Roman Rouzier, Charles M. Perou et al. Clinical Cancer Research
  3. T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028 (2018)
    Patrick A. Ott, Yung‐Jue Bang et al. Journal of Clinical Oncology

Immediate Impact

4 by Nobel laureates 11 from Science/Nature 75 standout
Sub-graph 1 of 18

Citing Papers

A pan-cancer analysis of the microbiome in metastatic cancer
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
6 intermediate papers

Works of Mark Ayers being referenced

T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
2018 Standout
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout

Author Peers

Author Last Decade Papers Cites
Mark Ayers 5075 2630 2449 55 7.6k
Anna C. Obenauf 3940 2264 4042 34 8.7k
Anne F. Schott 4302 2504 2386 92 6.8k
Hartmut Koeppen 4897 1692 4842 115 9.0k
Amreen Husain 4562 1406 1454 71 8.0k
Priti Lal 2958 1961 2493 124 6.6k
Peter S. Hammerman 2943 2091 4205 84 7.9k
Helen X. Chen 4050 1937 3819 83 8.7k
Luciana Molinero 6401 2072 1595 101 8.9k
Talia Golan 5148 2235 1965 168 6.9k
Robert Radinsky 6171 2207 4491 126 10.2k

All Works

Loading papers...

Rankless by CCL
2026